BRANDON WATSON: Open Payments
NPI 1972125748 · TRAVELERS REST, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,042 in 68 payments from 16 companies in 2025. Trend: 2023 $268 · 2024 $1,149 · 2025 $1,042
Food & beverage: $1,042
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $223 |
| AstraZeneca Pharmaceuticals LP | 7 | $151 |
| Novo Nordisk Inc | 8 | $130 |
| PFIZER INC. | 6 | $103 |
| Lilly USA, LLC | 4 | $65 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| Edwards Lifesciences Corporation | 1 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
Products named: VRAYLAR, Ozempic, UBRELVY, FARXIGA, MOUNJARO, NURTEC ODT, XIFAXAN, QULIPTA.
Industry payments across SC — which companies pay providers there.
